MedPharm announces expansion of US Center of Excellence

MedPharm Ltd has announced the expansion of its US Center of Excellence in Durham, North Carolina in response to increasing service demand for its topical and transdermal formulation development and performance testing services.

CEO Eugene Ciolfi
An investment of $4M in facility expansion and equipment will more than triple the existing footprint of the current US facility to 25,000 sq/feet. In parallel, the company has substantially increased its LC/MS capacity and the automation of sample handling.

The expansion creates additional laboratory space for MedPharm to de-risk its customers’ development programs by carrying out expanded topical dosage formulation development services and innovative performance testing on topical and transdermal pharmaceutical products. Recently published FDA and EMEA guidance’s on demonstrating generic equivalence for topical medicines, as well as the growing interest in developing new topical drugs, is fueling this demand.

As part of the investment, MedPharm has installed the latest Waters LC-MS/MS to manage the increasing demand for bio-analysis. This new model is equipped with the latest UPLC for rapid separation and method development and offers mass spectrometry detection at picogram levels.

Click here to read the full release.

Notes to editors

About MedPharm
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established R&D centres in the USA and UK and has its global HQ in Guildford, UK.